Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.75
Delayed Data
As of 4:00pm ET
 -0.10 / -1.71%
Today’s Change
5.25
Today|||52-Week Range
15.75
+2.68%
Year-to-Date

Today’s Trading

Previous close5.85
Today’s open5.83
Day’s range5.71 - 5.91
Volume122,631
Average volume (3 months)263,917
Market cap$147.1M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+15.95%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...-0.05-0.88%
NVIVInVivo Therapeutics ...0.000.00%
--Wang On Group Ltd0.000.00%
EVGNEvogene Ltd+0.09+1.71%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateApril 10, 2017
EPS forecast (this quarter)-$0.61
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs